Clinical Trial Update: Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing albumin dosing regimens of 4 g/L versus 8 g/L to prevent post-paracentesis circulatory dysfunction in patients with tense asc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis with Ascites

Drugs mentioned

• Albumin (human serum albumin) (albumin)

Snippet

Sponsor: University of Turin, Italy | Conditions: Tense Ascites in Cirrhosis | Phase 2 | Status: UNKNOWN